Clinical Trials Browser

Recruiting × tipifarnib × 90 days × Clear all

NCT06540963 2026-03-02

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Phase 2 Recruiting

Neuroblastoma